Elon Musk’s official announcement to launch Terafab received ample investor acceptance, sending the share price to its new highs. The announcement ignited excitement around the company’s new production targets and long-term manufacturing ambitions. While the announcement sparked a short-term rally, Wall Street analysts are worried about the sheer technical difficulty and massive expenses centered on the project. Analysts remain cautious about the high expectations, major capital risks, and unrealistic timelines associated with the Terafab project.
About Terafab and Why It Matters — Unfolding a $20 Billion Moonshot
Terafab is the joint venture between Tesla, SpaceX, and xAI, announced by Elon Musk on the Austin stage on March 21, describing it as the most epic chip-building project in history so far. Terafab is a $20 billion project that aims to manufacture its own AI chips at scale within the US, consolidating every stage of semiconductor production under one roof. By launching the project, Tesla plans to end its reliance on external suppliers like TSMC, Samsung, and other AI chip manufacturers for powering its Cybercab Robotaxis, Optimus humanoid robots, and self-driving system.
The primary target of Terafab is to develop a manufacturing ecosystem in Austin, Texas, capable of producing one terawatt of annual computing power using advanced 2nm process technology. The factory is expected to produce 100–200 billion chips yearly, with 80% apportioned to aerospace requirements and 20% to terrestrial applications.
Stock Jump After Terafab Reveal—Inside the Market Reaction
Tesla stock has always been sensitive to the announcements centered on innovations, expansions, and acquisition plans. The market reaction was positive to the project reveal as Tesla shares experienced a substantial rise of approximately 3.5% at $380.85 on the last trading day, March 23, 2026. The trading volume surged by 18% above the 3-month average and reached 72.6 million shares. Tesla shares posted a 2.79% intraday gain, reflecting investors’ enthusiasm for Terafab news.
Wall Street’s Bigger Questions—Explained
Despite the excitement over the ambitious project reveal, many analysts raised red flags regarding the operational and financial risks associated with the execution of Terafab. Analysts’ biggest question about the project revolves around the cost and execution risk at extreme scale.
Dan Levy, analyst at Barclays, warned that Terafab’s capital expenditure will be immense for the EV automaker. Referencing the Taiwan Semiconductor Manufacturing Company, which had spent about $40 billion on the project, Levy stated that Terafab’s $20 billion estimate is likely a floor, not a ceiling, and the real cost will shoot above $100 billion, which is massive and could strain the long-term financial health of Tesla. The analyst contends that the project will follow a more conservative timeline, arguing that Terafab’s success depends on an incremental expansion rather than an overnight breakthrough.
Analysts’ bigger question is whether Tesla can deliver the project within the budget and timeline, alongside maintaining the margins. Investors perceive Tesla’s spending to build an in-house chip manufacturing facility as a massive win that enables the company to dominate tech, AI, and robotics.
Tesla Stock—Buy, Hold, or Sell?
Investors view Terafab as Tesla’s groundbreaking initiative to insulate itself from global supply chain volatility through consolidating the entire semiconductor stack under one roof. Although analysts warn that the initiative is a double-edged sword, investors are betting on Tesla’s ability to secure its future as a vertically integrated AI and robotics powerhouse. Most of the analysts give Tesla a hold rating as they are concerned about Tesla’s ability to win the project within the estimated cost and time frame.
